MIMETAS BV
MIMETAS BV, headquartered in the Netherlands, is a pioneering company in the field of organ-on-a-chip technology. Founded in 2013, MIMETAS has established itself as a leader in the life sciences industry, focusing on innovative solutions for drug development and disease modelling. The company’s flagship products, including the OrganoPlate® platform, enable researchers to create complex, human-relevant tissue models that mimic in vivo conditions, setting them apart in the market. With a commitment to advancing personalised medicine, MIMETAS has achieved significant milestones, including collaborations with major pharmaceutical companies and academic institutions. Their unique approach to high-throughput screening and disease modelling has positioned them as a key player in the biotechnology sector, driving forward the future of drug discovery and development.
DitchCarbon Score
How does MIMETAS BV's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MIMETAS BV's score of 5 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MIMETAS BV's reported carbon emissions
In 2020, MIMETAS BV reported total carbon emissions of approximately 1,430,000,000 kg CO2e, which includes 1,240,000,000 kg CO2e from Scope 2 emissions and 12,000,000,000 kg CO2e from Scope 3 emissions. The Scope 1 and 2 emissions combined were about 1,430,000,000 kg CO2e. In 2019, the company recorded similar figures, with total emissions of about 1,380,000,000 kg CO2e for Scope 1 and 2, alongside 11,600,000,000 kg CO2e from Scope 3. Over the years, MIMETAS has shown a slight decrease in Scope 2 emissions, from 1,500,000,000 kg CO2e in 2016 to 1,240,000,000 kg CO2e in 2020. Despite these figures, MIMETAS BV has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of defined reduction strategies suggests a need for further commitment to climate action within the industry context.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - |
| Scope 2 | 1,500,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MIMETAS BV is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
